SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-001618
Filing Date
2021-12-17
Accepted
2021-12-17 16:30:28
Documents
1
Period of Report
2021-10-06

Document Format Files

Seq Description Document Type Size
1 effector_fm4oct62021.html 4  
1 effector_fm4oct62021.xml 4 6085
  Complete submission text file 0000905718-21-001618.txt   7693
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Reporting) CIK: 0001397144 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 211501963

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations